Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 1/20 | 0.43 |
| ▸ | FNTB | P49356 | 1/20 | 0.43 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL822099 | 0.80 | CES1 (0.55) | CES1CES2AKR1B1TSHRKMT2A | |
| SCHEMBL575074 | 0.80 | AKR1B1 (0.62) | CES1CES2AKR1B1TSHRKMT2A | |
| SCHEMBL2241627 | 0.80 | CES1 (0.55) | CES1CES2AKR1B1TSHRKMT2A | |
| SCHEMBL12095508 | 0.80 | CES1 (0.55) | CES1CES2AKR1B1TSHRKMT2A | |
| SCHEMBL162822 | 0.79 | CES1 (0.54) | CES1CES2AKR1B1TSHRKMT2A | |
| Ammonia Solution, Strong SCHEMBL27465072 | 0.78 | CES1 (0.52) | CES1CES2AKR1B1TSHRKMT2A | |
| Ammonia Solution, Strong SCHEMBL574785 | 0.78 | CES1 (0.52) | CES1CES2AKR1B1TSHRKMT2A | |
| SCHEMBL3855307 | 0.78 | CES1 (0.52) | CES1CES2AKR1B1TSHRKMT2A | |
| SCHEMBL6077860 | 0.78 | CES1 (0.52) | CES1CES2AKR1B1TSHRKMT2A | |
| SCHEMBL6348874 | 0.76 | CES1 (0.64) | CES1CES2AKR1B1TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230019712-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| US-20230020436-A1 | NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| US-20230011996-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2023-01-12 | — | — | US | disclosed |
| US-20210395233-A1 | NEW COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-12-23 | — | — | US | disclosed |
| US-20200388768-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-12-10 | — | — | US | disclosed |
| US-20200388767-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-12-10 | — | — | US | disclosed |
| US-10811612-B2 | Organic electroluminescence device and electronic apparatus provided with the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-10-20 | — | — | US | disclosed |
| US-10804474-B2 | Organic electroluminescence device and electronic apparatus provided with the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-10-13 | — | — | US | disclosed |
| US-10777752-B2 | Organic electroluminescence device and electronic apparatus provided with the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-09-15 | — | — | US | disclosed |
| US-10763441-B2 | Organic electroluminescence device and electronic apparatus provided with the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-09-01 | — | — | US | disclosed |
| US-10593889-B1 | Compound and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2020-03-17 | — | — | US | disclosed |
| EP-3605635-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | Idemitsu Kosan Co., Ltd. (JP) | 2020-02-05 | — | — | EP | disclosed |
| CN-101945905-B | Resin composition | ASAHI KASEI E MATERIALS CORP | 2013-06-26 | — | — | CN | disclosed |
| US-20110282063-A1 | METHOD OF PRODUCING A DIAZAFLUORENE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2011-11-17 | — | — | US | disclosed |
| US-20080161574-A1 | DIAZAFLUORENE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2008-07-03 | — | — | US | disclosed |
| EP-0410379-B1 | Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins | MERRELL DOW PHARMA (US) | 1996-01-31 | — | — | EP | disclosed |
| US-5068465-A | Hypotensive agents or enzyme inhibitors for treatment of hypertension | MERRELL DOW PHARMACEUTICALS INC. (US) | 1991-11-26 | — | — | US | disclosed |
| EP-0410379-A2 | Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins | MERRELL DOW PHARMACEUTICALS INC. (US) | 1991-01-30 | — | — | EP | disclosed |
| EP-0410380-A2 | Novel process for the synthesis of 2-fluoro-1-olefins | MERRELL DOW PHARMACEUTICALS INC. (US) | 1991-01-30 | — | — | EP | disclosed |
| US-4981868-A | ENZYME INHIBITORS, HYPOTENSIVES | MERRELL DOW PHARMACEUTICAL (US) | 1991-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161574-A1 | DIAZAFLUORENE COMPOUND | AFF1, NPFFR1, AFF2 | CES1 1698/4885CES2 1918/4885AKR1B1 1622/4885 |
| US-20230011996-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | RER1, RPS19, ESR1 | CES1 2657/4885CES2 1344/4885AKR1B1 2379/4885 |
| US-20210395233-A1 | NEW COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | AHR, UQCRB, AOC2 | CES1 3299/4885CES2 1639/4885AKR1B1 687/4885 |
| US-10593889-B1 | Compound and organic electroluminescence device | LEF1, NOM1, RIF1 | CES1 3038/4885CES2 1883/4885AKR1B1 2614/4885 |
| US-10811612-B2 | Organic electroluminescence device and electronic apparatus provided with the same | RER1, RPS19, ESR1 | CES1 2316/4885CES2 1117/4885AKR1B1 2408/4885 |
| US-10777752-B2 | Organic electroluminescence device and electronic apparatus provided with the same | RER1, RPS19, MRPS22 | CES1 3967/4885CES2 1418/4885AKR1B1 2261/4885 |
| US-20110282063-A1 | METHOD OF PRODUCING A DIAZAFLUORENE COMPOUND | AFF1, AFF2, AFF4 | CES1 1318/4885CES2 1011/4885AKR1B1 1380/4885 |
| US-20230020436-A1 | NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | MRPS22, RER1, EMC2 | CES1 4593/4885CES2 2368/4885AKR1B1 3994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.